BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31108228)

  • 1. Risk of Gastrointestinal Bleeding Increases With Combinations of Antithrombotic Agents and Patient Age.
    Abraham NS; Noseworthy PA; Inselman J; Herrin J; Yao X; Sangaralingham LR; Cornish G; Ngufor C; Shah ND
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):337-346.e19. PubMed ID: 31108228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Machine Learning Approaches for Predicting Gastrointestinal Bleeds in Patients Receiving Antithrombotic Treatment.
    Herrin J; Abraham NS; Yao X; Noseworthy PA; Inselman J; Shah ND; Ngufor C
    JAMA Netw Open; 2021 May; 4(5):e2110703. PubMed ID: 34019087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of lower and upper gastrointestinal bleeding, transfusions, and hospitalizations with complex antithrombotic therapy in elderly patients.
    Abraham NS; Hartman C; Richardson P; Castillo D; Street RL; Naik AD
    Circulation; 2013 Oct; 128(17):1869-77. PubMed ID: 24025594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal Trends, Predictors, and Outcomes of In-Hospital Gastrointestinal Bleeding Associated With Percutaneous Coronary Intervention.
    Patel NJ; Pau D; Nalluri N; Bhatt P; Thakkar B; Kanotra R; Agnihotri K; Ainani N; Patel N; Patel N; Shah S; Kadavath S; Arora S; Sheikh A; Badheka AO; Lafferty J; Alfonso C; Cohen M
    Am J Cardiol; 2016 Oct; 118(8):1150-1157. PubMed ID: 27642112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fewer gastrointestinal bleeds with ticagrelor and prasugrel compared with clopidogrel in patients with acute coronary syndrome following percutaneous coronary intervention.
    Abraham NS; Yang EH; Noseworthy PA; Inselman J; Yao X; Herrin J; Sangaralingham LR; Ngufor C; Shah ND
    Aliment Pharmacol Ther; 2020 Aug; 52(4):646-654. PubMed ID: 32657466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
    Staerk L; Lip GY; Olesen JB; Fosbøl EL; Pallisgaard JL; Bonde AN; Gundlund A; Lindhardt TB; Hansen ML; Torp-Pedersen C; Gislason GH
    BMJ; 2015 Nov; 351():h5876. PubMed ID: 26572685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.
    van Rein N; Heide-Jørgensen U; Lijfering WM; Dekkers OM; Sørensen HT; Cannegieter SC
    Circulation; 2019 Feb; 139(6):775-786. PubMed ID: 30586754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitor Utilization in Veteran Patients on Combined Antithrombotic Therapy and Validation of Simplified Bleeding Risk Score.
    Patil T; Murphy K; Woodard L; Lebrecht M
    Pharmacotherapy; 2020 Dec; 40(12):1219-1227. PubMed ID: 33073362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of gastrointestinal bleeding associated with oral anticoagulation and non-steroidal anti-inflammatory drugs in patients with atrial fibrillation: a nationwide study.
    Olsen AS; McGettigan P; Gerds TA; Fosbøl EL; Olesen JB; Sindet-Pedersen C; Staerk L; Lock Hansen M; Pallisgaard JL; Køber L; Torp-Pedersen C; Gislason GH; Lamberts M
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):292-300. PubMed ID: 31742339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Antiplatelet Agents and Anticoagulants in Patients with Gastrointestinal Bleeding.
    Abraham NS
    Gastrointest Endosc Clin N Am; 2015 Jul; 25(3):449-62. PubMed ID: 26142031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet patterns and outcomes in patients with atrial fibrillation not prescribed an anticoagulant after stroke.
    Chang KW; Xian Y; Zhao X; Mi X; Matsouaka R; Schwamm LH; Shah S; Lytle BL; Smith EE; Bhatt DL; Fonarow GC; Hsu JC
    Int J Cardiol; 2020 Dec; 321():88-94. PubMed ID: 32805327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute gastrointestinal bleeding among patients on antiplatelet and anticoagulant therapy after percutaneous coronary intervention.
    Sveinsdottir A; Gudmundsdottir IJ; Hreinsson JP; Andersen K; Björnsson ES
    Scand J Gastroenterol; 2021 Jun; 56(6):733-739. PubMed ID: 33794728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
    Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
    Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrointestinal bleeding in cardiac patients: epidemiology and evolving clinical paradigms.
    Abraham NS
    Curr Opin Gastroenterol; 2014 Nov; 30(6):609-14. PubMed ID: 25216111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic therapy in coronary artery disease patients with atrial fibrillation.
    Wei L; Su E; Liu W; Xing W; Liu X; Zhang Y; Wang S; Cheng Q; Qi D; Gao C
    BMC Cardiovasc Disord; 2020 Jul; 20(1):323. PubMed ID: 32631244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When and How to Combine Antiplatelet and Anticoagulant Drugs?
    Espinola-Klein C
    Hamostaseologie; 2022 Feb; 42(1):73-79. PubMed ID: 35196733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal bleeding risk with rivaroxaban vs aspirin in atrial fibrillation: A multinational study.
    Fanning L; Wong ICK; Li X; Chan EW; Mongkhon P; Man KKC; Wei L; Leung WK; Darzins P; Bell JS; Ilomaki J; Lau WCY
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1550-1561. PubMed ID: 32936997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis in patients with atrial fibrillation and CHA2DS2-VASc Score = 0 in a community-based cohort study.
    Taillandier S; Olesen JB; Clémenty N; Lagrenade I; Babuty D; Lip GY; Fauchier L
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):708-13. PubMed ID: 22268375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.